VeriMomDois-je éviter retinoyl oligopeptide-112 pendant la grossesse ? | VeriMom
No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- retinoyl oligopeptide-112 est-il sûr pendant la grossesse ?
- No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
- retinoyl oligopeptide-112 est-il sûr pendant l'allaitement ?
- No specific data on milk excretion for this ingredient were located. Topical retinoids are generally advised against in pregnancy and often avoided during breastfeeding as a precaution; because the compound contains a retinoyl group there is a class‑based/theoretical concern (h=1, m=1). Measured systemic absorption for retinoid‑peptide conjugates was not found, so exposure scored as low but measurable (e=1).
- retinoyl oligopeptide-112 est-il sûr pour la peau de bébé ?
- Infant skin has higher permeability; per your rules increase exposure by +1 when adult exposure is measurable. No infant‑specific safety data were found for Retinoyl Oligopeptide‑112; therefore h and m remain the same as adults (structural/class concern), and e is increased to 2 for 0–3‑year‑old skin. Keep infants’ direct contact with treated skin minimal (no application to chest/areas the baby may contact) in the absence of data.
- Comment VeriMom évalue-t-il retinoyl oligopeptide-112 ?
- VeriMom évalue retinoyl oligopeptide-112 à 13/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à retinoyl oligopeptide-112 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à retinoyl oligopeptide-112 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.